Guidelines

Highlights in aggressive lymphomas

February 2016
Allogeneic stem cell transplantation at ASH 2015

February 2016
Novelties in the treatment of sickle cell disease

February 2016
Clinical highlights in hemophilia

February 2016
New hematology reimbursements in Belgium

February 2016
Program

January 2016
O.1 Infusion of mesenchymal stem cells (MSC) as treatment for steroid refractory acute graft-versus-host study (aGVHD): a multicenter prospective phase II study of the BHS

January 2016
O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

January 2016
O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin

January 2016
O.4 SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma

January 2016

Top